心肺复苏中的血管加压药:随机试验的网络Meta分析
该网络Meta分析纳入28项随机对照试验、共14,848例成人心脏骤停患者,比较12个治疗组。主要发现:仅肾上腺素、血管加压素和甲泼尼龙联合治疗与自主循环恢复及良好神经功能存活的可能性增加相关,优于包括肾上腺素在内的多个对照。单用肾上腺素与其他任何对照相比,死亡率及良好神经功能结局无显著差异。作者结论认为,随机证据既不支持也不反对心脏骤停期间使用肾上腺素。
要点
- 在成人心脏骤停随机试验中,仅肾上腺素、血管加压素和甲泼尼龙联合治疗与良好神经功能存活率改善相关,尤其院内心脏骤停。
- 单用肾上腺素与其他任何对照相比,死亡率及良好神经功能结局无显著差异。
- 该网络Meta分析纳入28项随机对照试验、14,848例患者,比较12个治疗组。
- 作者结论:随机证据既不足以支持也不足以反对心脏骤停期间使用肾上腺素。
适用人群与场景
- 成人心脏骤停接受心肺复苏的患者。
研究设计与关键结果
- 研究设计:网络Meta分析,采用频率学派方法;检索PubMed、Embase、BioMed Central和Cochrane Central注册库(截至2017年4月1日)。
- 纳入28项随机对照试验,共14,848例患者,分为12个治疗组。
- 仅肾上腺素、血管加压素和甲泼尼龙联合治疗与自主循环恢复及良好神经功能存活的可能性增加相关,优于包括肾上腺素在内的多个对照。
- 单用肾上腺素与其他任何对照相比,死亡率及良好神经功能结局无显著差异。
- 作者结论:在成人心脏骤停的随机试验中,仅肾上腺素、血管加压素和甲泼尼龙联合治疗与良好神经功能存活率改善相关,尤其院内心脏骤停;随机证据既不足以支持也不足以反对使用肾上腺素。
证据类型、等级与局限
- 证据类型:网络Meta分析(随机对照试验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Several randomized controlled trials have compared adrenaline (epinephrine) with alternative therapies in patients with cardiac arrest with conflicting results. Recent observational studies suggest that adrenaline might increase return of spontaneous circulation but worsen neurologic outcome. We systematically compared all the vasopressors tested in randomized controlled trials in adult cardiac arrest patients in order to identify the treatment associated with the highest rate of return of spontaneous circulation, survival, and good neurologic outcome.
DESIGN: Network meta-analysis.
PATIENTS: Adult patients undergoing cardiopulmonary resuscitation.
INTERVENTIONS: PubMed, Embase, BioMed Central, and the Cochrane Central register were searched (up to April 1, 2017). We included all the randomized controlled trials comparing a vasopressor with any other therapy. A network meta-analysis with a frequentist approach was performed to identify the treatment associated with the highest likelihood of survival.
MEASUREMENTS AND MAIN RESULTS: Twenty-eight studies randomizing 14,848 patients in 12 treatment groups were included. Only a combined treatment with adrenaline, vasopressin, and methylprednisolone was associated with increased likelihood of return of spontaneous circulation and survival with a good neurologic outcome compared with several other comparators, including adrenaline. Adrenaline alone was not associated with any significant difference in mortality and good neurologic outcome compared with any other comparator.
CONCLUSIONS: In randomized controlled trials assessing vasopressors in adults with cardiac arrest, only a combination of adrenaline, vasopressin, and methylprednisolone was associated with improved survival with a good neurologic outcome compared with any other drug or placebo, particularly in in-hospital cardiac arrest. There was no significant randomized evidence to support neither discourage the use of adrenaline during cardiac arrest.
参考来源
- Belletti A, Benedetto U, Putzu A, et al. Vasopressors During Cardiopulmonary Resuscitation. A Network Meta-Analysis of Randomized Trials. Crit Care Med. 2018. PMID: 29652719. doi:10.1097/CCM.0000000000003049
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。